谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase III Randomized, Open-Label, Multicenter Trial (BRIM3) Comparing BRAF Inhibitor Vemurafenib with Dacarbazine (DTIC) in Patients with V600E BRAF-mutated Melanoma (ASCO 2011 Melanoma, Abstract LBA4)

Paul Lorigan,Paul B. Chapman,Axel Hauschild,Caroline Robert,James Larkin, J.B.A.G. Haanen, A. Ribas,David Hogg, Steven O’Day,Paolo A. Ascierto,Alessandro Testori,Reinhard Dummer, J. A. Sosman,Claus Garbe, R. J. Lee, K. B. Nolop, B. Nelson,Jean‐Jacques Grob, Keith T. Flaherty, Grant A. McArthur

openalex（2011）

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要